481 parallel-computing-numerical-methods positions at University of Maryland, Baltimore
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
concerning an ADA request for reasonable accommodation will be responded to from this email address. The University of Maryland, Baltimore prohibits sex discrimination in any education program or activity
-
. Ability to perform laboratory procedures usingapplicable equipment and techniques; to communicate effectively both orally and in writing; to use computers and related software applications; to lift
-
additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension or optional retirement plan/ORP) that must be selected and is effective on your date
-
integration of transplanted stem cells. We expect the fellow to be highly motivated, independent and innovative. The applicant can expect to receive career mentoring from faculty of the Program of Image Guided
-
discrimination in any education program or activity that it operates. Individuals may report concerns or questions to the Title IX Coordinator. Read the UMB Notice of Non-Discrimination for more information
-
at the Maryland Proton Treatment Center and/or another of our clinical sites. The Department of Radiation Oncology’s clinical program has 21 physicians, a fellow and 12 residents. The University of Maryland
-
, collaborative academic leadership, clinical and research program development, educational excellence, successful faculty recruitment and retention, community and philanthropic engagement, and the design and
-
residents, as the site serves as the ambulatory continuity practice for the UMMC-MTC Internal Medicine residency program. Finally, this position will engage in community outreach and patient education as
-
to participate in educational training events for students in the Physician Assistant Program and the School of Pharmacy. Ideal candidates will use acting skills to demonstrates basic or complex symptom(s) or
-
a dynamic, translational research program focused on engineering oncolytic viruses to target pancreatic ductal adenocarcinoma (PDAC) and modulate the tumor microenvironment for enhanced immunotherapy